Physician profile
Alan John Weiss
NPI 1194735183
$847.49
in general payments reported to CMS, 2019-2025
17 companies · $44.37 in 2025
The $44.37 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $259 · 2020: $70.66 · 2021: $12.11 · 2023: $173 · 2024: $289 · 2025: $44.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $506.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $505.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $168.47 | 2019-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Astellas Pharma US INC | $94.65 | 2023-2025 | Veozah |
| Idorsia Pharmaceuticals US INC | $88.98 | 2023-2024 | Quviviq |
| Sumitomo Pharma America, INC. | $85.39 | 2023-2024 | Gemtesa |
| Celgene Corporation | $85.03 | 2019-2020 | |
| Puma Biotechnology, INC. | $58.73 | 2019-2020 | |
| Axsome Therapeutics, INC. | $44.01 | 2024 | Auvelity |
| Smith+Nephew, INC. | $37.14 | 2024 | Grafix Pl, Stravix Mesh, Oasis |
| Janssen Biotech, INC. | $34.93 | 2019-2020 | |
| Genzyme Corporation | $25.73 | 2023 | |
| Merck Sharp & Dohme LLC | $24.65 | 2019 | |
| Agios Pharmaceuticals, INC. | $19.42 | 2019 | |
| Aclaris Therapeutics, INC. | $18.98 | 2019 | |
| Kedrion Biopharma, INC. | $17.30 | 2024 | Gammaked, Rhogam Ultra-Filtered Plus, Albuked |
| Foundation Medicine, INC. | $16.10 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $15.87 | 2020 | |
| Novo Nordisk INC | $12.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Weiss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.